Literature DB >> 8031047

Pharmacokinetics of dideoxyinosine in neonatal pigtailed macaques.

C M Pereira1, C Nosbisch, J D Unadkat.   

Abstract

To determine whether age affects the pharmacokinetics of dideoxyinosine in neonatal pigtailed macaques (Macaca nemestrina), dideoxyinosine (10 mg/kg of body weight) was administered as a single intravenous bolus to macaques at ages < 1 week, 1 month, and 4 months. Clearance from plasma at < 1 week of age was significantly lower (P < 0.05) and the terminal half-life was significantly higher than the corresponding values obtained at 1 month and 4 months of age. Our data indicate that the pharmacokinetics of dideoxyinosine change significantly with age in M. nemestrina.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031047      PMCID: PMC284543          DOI: 10.1128/AAC.38.4.787

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  Considerations for the evaluation of antiretroviral agents in infants and children infected with human immunodeficiency virus: a perspective from the National Cancer Institute.

Authors:  P A Pizzo
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

2.  Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

Authors:  F M Balis; P A Pizzo; K M Butler; M E Hawkins; P Brouwers; R N Husson; F Jacobsen; S M Blaney; J Gress; P Jarosinski
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

3.  Glomerular filtration rate during the period of adaptation to extrauterine life.

Authors:  R D Leake; C W Trygstad
Journal:  Pediatr Res       Date:  1977-09       Impact factor: 3.756

4.  Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection.

Authors:  N R Hartman; R Yarchoan; J M Pluda; R V Thomas; K S Marczyk; S Broder; D G Johns
Journal:  Clin Pharmacol Ther       Date:  1990-05       Impact factor: 6.875

5.  Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer.

Authors:  A Lopez-Anaya; J D Unadkat; L A Schumann; A L Smith
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

6.  In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine.

Authors:  R Yarchoan; H Mitsuya; R V Thomas; J M Pluda; N R Hartman; C F Perno; K S Marczyk; J P Allain; D G Johns; S Broder
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

7.  Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate.

Authors:  A Lopez-Anaya; J D Unadkat; L A Schumann; A L Smith
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

8.  Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques.

Authors:  C M Pereira; C Nosbisch; H R Winter; W L Baughman; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial.

Authors:  G L Drusano; G J Yuen; J S Lambert; M Seidlin; R Dolin; F T Valentine
Journal:  Ann Intern Med       Date:  1992-04-01       Impact factor: 25.391

10.  Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

Authors:  C A Knupp; W C Shyu; R Dolin; F T Valentine; C McLaren; R R Martin; K A Pittman; R H Barbhaiya
Journal:  Clin Pharmacol Ther       Date:  1991-05       Impact factor: 6.875

View more
  1 in total

1.  Pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in the neonatal macaque (Macaca nemestrina).

Authors:  R D Keller; C Nosbisch; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.